mu-Opioid stimulation of isolated parietal sheep peritoneum decreases peritoneal permeability in vitro

Sotirios Zarogiannis1, Konstantinos Vogiatzidis, Chryssi Hatzoglou

  • 1Department of Nephrology, Medical School, University of Thessaly, Larissa, Greece.

Insights

Morphine applied to the basolateral side of sheep parietal peritoneum rapidly increased transmesothelial electrical resistance (RTM), indicating micro-opioid receptors influence peritoneal permeability. This suggests potential therapeutic applications in peritoneal dialysis.

Area of Science:

  • Physiology
  • Pharmacology
  • Renal Science

Background:

  • The peritoneal mesothelium is a key barrier regulating ion transport during peritoneal dialysis.
  • Previous research indicated micro-opioid influence on serosal membrane permeability.
  • Morphine was shown to decrease ionic permeability in pleural and pericardial membranes.

Purpose of the Study:

  • To investigate the effect of morphine on the transmesothelial electrical resistance (RTM) of isolated parietal sheep peritoneum.
  • To determine if micro-opioid receptors are present in the parietal peritoneum and their location.

Main Methods:

  • Ussing chamber experiments were performed on isolated parietal sheep peritoneum.
  • Morphine (10(-9) mol/L) was applied apically and basolaterally to the peritoneum.
  • Transmesothelial electrical resistance (RTM) was measured before and after morphine application at 37°C.

Main Results:

  • Basolateral application of morphine significantly increased RTM by 24% within 1 minute (p < 0.01).
  • Apical application of morphine did not result in a significant change in RTM.
  • The control RTM was measured at 20.26 +/- 0.57 Omega x cm2.

Conclusions:

  • Basolateral morphine rapidly affects parietal peritoneum permeability, as indicated by increased RTM.
  • The findings suggest the presence of basolaterally located micro-opioid receptors in the parietal peritoneum.
  • Further investigation into the clinical implications for peritoneal dialysis is warranted.

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...